Abstract
X-chromosome inactivation (XCI) is a process involved in the pathogenesis of several diseases. In this mini review, we discuss the known mechanisms associated with XCI, when and how does it initiate, spreads and maintain, as well as the mechanisms that allow some genes to escape from it. We address the skewed XCI, condition in which the process are not fully randomized and its consequences to the phenotype of some pathologies. We debate about the known pathologies implicated, including X unbalanced rearrangements, X-autosomal balanced translocations, Turner and Klinefelter syndromes and also for X-linked diseases and its consequences in males and females. Some pathologies are discussed more in detail such as intellectual disability with a recognized relationship with XCI. Finally, possible future implications of genomic therapy and treatment of patients and list of areas that need further research on this topic are addressed.
Similar content being viewed by others
References
Aarabi M., Kessler E., Madan-Khetarpal S., Surti U., Bellissimo D., Rajkovic A. et al. 2019 Autism spectrum disorder in females with ARHGEF9 alterations and a random pattern of X chromosome inactivation. Eur. J. Med. Genet. 62, 239–242.
Berletch J. B., Yang F., Xu J., Carrel L. and Disteche C. M. 2011 Genes that escape from X inactivation. Hum. Genet. 130, 237–245.
Bicocchi M. P., Migeon B. R., Pasino M., Lanza T., Bottini F., Boeri E. et al. 2005 Familial nonrandom inactivation linked to the X inactivation centre in heterozygotes manifesting haemophilia A. Eur. J. Hum. Genet. 13, 635–640.
Blaschke R. J. and Rappold G. 2006 The pseudoautosomal regions, SHOX and disease. Curr. Opin. Genet. Dev. 16, 233–239.
Cantone I. and Fisher A. G. 2017 Human X chromosome inactivation and reactivation: implications for cell reprogramming and disease. Philos. Trans. R. Soc. London B Biol. Sci. 372, 20160358.
Disteche C. and Berletch J. 2015 X-chromosome Inactivation and Escape. J. Genet. 94, 591–598.
Disteche C. 2016 Dosage compensation of the sex chromosomes and autosomes. Semin. Cell Dev. Biol. 56, 9–18.
Dixon-McDougall T. and Brown C. 2016 The making of a Barr body: the mosaic of factors that eXIST on the mammalian inactive X chromosome. Biochem. Cell Biol. 94, 56–70.
Echevarria L., Benistan K., Toussaint A., Dubourg O., Hagege A. A., Eladari D. et al. 2016 X-chromosome inactivation in female patients with Fabry disease. Clin. Genet. 89, 44–54.
Engreitz J. M., Pandya-Jones A., McDonel P., Shishkin A., Sirokman K., Surka C. et al. 2013 The Xist lncRNA exploits three-dimensional genome architecture to spread across the X chromosome. Science 341, 1237973.
Fang H., Disteche C. and Berletch J. 2019 X inactivation and escape: epigenetic and structural features. Front. Cell Dev. Biol. 7, 219.
Galupa R. and Heard E. 2018 X-chromosome inactivation: a crossroads between chromosome architecture and gene regulation. Annu. Rev. Genet. 52, 535–566.
Gieldon L., Mackenroth L., Betcheva-Krajcir E., Rump A., Beck-Wödl S., Schallner J. et al. 2017 Skewed X-inactivation in a family with DLG3-associated X-linked intellectual disability. Am. J. Med. Genet. A 173, 2545–2550.
Halmai J. A. N. M., Deng P., Gonzalez C. E., Coggins N. B., Cameron D., Carter J. L. et al. 2020 Artificial escape from XCI by DNA methylation editing of the CDKL5 gene. Nuclic Acids Res. 48, 2372–2387.
Jiang J., Jing Y., Cost G. J., Chiang J. C., Kolpa H. J., Cotton A. M. et al. 2013 Translating dosage compensation to trisomy 21. Nature 500, 296–300.
Leppig K. A. and Disteche C. M. 2001 Ring X and other structural X chromosome abnormalities: X inactivation and phenotype. Semin. Reprod. Med. 19, 147–157.
Mattei M. G., Mattei J. F., Ayme S. and Giraud F. 1982 X-autosome translocations: cytogenetic characteristics and their consequences. Hum. Genet. 61, 295–309.
Monk M., Boubelik M. and Lehnert S. 1987 Temporal and regional changes in DNA methylation in the embryonic, extraembryonic and germ cell lineages during mouse embryo development. Development 99, 371–382.
Monkhorst K., Jonkers I., Rentmeester E., Grosveld F. and Gribnau J. 2008 X inactivation counting and choice is a stochastic process: evidence for involvement of an X-linked activator. Cell 132, 410–421.
Payer B. 2016 Developmental regulation of X-chromosome inactivation. Semin. Cell Dev. Biol. 56, 88–99.
Pinter S. F., Sadreyev R. I., Yildirim E., Jeon Y., Ohsumi T. K. and Borowsky M. 2012 Spreading of X chromosome inactivation via a hierarchy of defined Polycomb stations. Genome. Res. 22, 1864–1876.
Plenge R. M., Stevenson R. A., Lubs H. A., Schwartz C. E. and Willard H. F. 2002 Skewed X-chromosome inactivation is a common feature of X-linked mental retardation disorders. Am. J. Hum. Genet. 71, 168–173.
Posynick B. J. and Brown C. J. 2019 Escape from X-chromosome inactivation: an evolutionary perspective. Front. Cell Dev. Biol. 7, 241.
Sierra I. and Anguera M. C. 2019 Enjoy the silence: X-chromosome inactivation diversity in somatic cells. Curr. Opin. Genet. Dev. 55, 26–31.
Shoukat H. M. H., Ghous G., Tarar Z. I., Shoukat M. M. and Ajmal N. 2020 Skewed inactivation of X chromosome: a cause of Hemophilia manifestation in carrier females. Cureus 12, e11216.
Sun Y., Luo Y., Qian Y., Chen M., Wang L., Li H. et al. 2019 Heterozygous deletion of the SHOX gene enhancer in two females with clinical heterogeneity associating with skewed XCI and escaping XCI. Front. Genet. 10, 1086.
Yamoto K., Saitsu H., Fujisawa Y., Kato F., Matsubara K., Fukami M. et al. 2020 Coffin-Lowry syndrome in a girl with 46, XX, t(X;11)(p22;p15)dn: Identification of RPS6KA3 disruption by whole genome sequencing. Clin. Case Rep. 8, 1076–1080.
Author information
Authors and Affiliations
Corresponding author
Additional information
Corresponding editor: Durgadas P. Kasbekar.
Rights and permissions
About this article
Cite this article
Pereira, G., Dória, S. X-chromosome inactivation: implications in human disease. J Genet 100, 63 (2021). https://doi.org/10.1007/s12041-021-01314-1
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12041-021-01314-1